EUVIMEDObjevte EUVIMED
Open access

A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles

Pegah Bagheri iD, Olga E Eremina iD, Nicholas Dorgan, Joshua Millstein, Cristina Zavaleta

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c08079 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2025. Written by Pegah Bagheri and 4 co-authors. Institution: Alfred E. Mann Department of Biomedical Engineering, University of Southern California, 36- McClintock Ave, Los Angeles, California 90089, United Sta…. Major MEDLINE topics: Breast Neoplasms, Metal Nanoparticles. Cited 5 times so far (Crossref); 81 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIBIB NIH HHS, U.S. Department of Health and Human Services.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Surface-enhanced Raman scattering nanoparticles (SERS NPs) are powerful tools for cellular-specific targeting and multiplexed biomarker detection. While they have been effective in labeling extracellular receptors, their application to intracellular targets has been limited by poor membrane permeability and endosomal trapping. Here, we present an optimized permeabilization and staining strategy that enables robust intracellular targeting with SERS NPs. Using breast cancer as a model system, we focused on three clinically relevant biomarkers─human epidermal growth factor 2 (HER2), which has both extracellular and intracellular targets, and estrogen receptor (ER) and progesterone receptor (PR), which are exclusively located inside the cells─to demonstrate the ability of our platform to detect both extracellular and intracellular targets. We conjugated SERS NPs with anti-HER2 antibodies to assess specific binding efficiency across breast cancer cell lines with varying HER2 expression. Flow cytometry revealed a strong correlation between HER2 expression and the specific-to-nonspecific binding ratio, demonstrating over 100-fold specificity for HER2-overexpressing cells. Fluorescence and Raman imaging confirmed high specificity and sensitivity. To extend this approach to intracellular targets, we evaluated three permeabilization agents─Tween 20, Triton X-100, and methanol─and identified Triton X-100 as optimal. It enabled ∼160 nm SERS NPs to access the intracellular space while preserving cell viability. SERS NPs conjugated with anti-ER and anti-PR antibodies revealed significant biomarker binding without compromising cell health, revealing the capability to specifically profile intracellular biomarkers with varying expression levels of ER and PR. Furthermore, multiplexed detection was demonstrated using a cocktail of SERS NPs targeting HER2, ER, and PR in mixed cell populations, mimicking clinical scenarios such as liquid biopsies. Even when target-positive cells were present at low abundance, the NPs retained selective binding and detection capability. Overall, our findings advance the potential of SERS NPs for enhancing breast cancer diagnostics through accurate, multiplexed biomarker targeting.

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsMetal NanoparticlesHumansSpectrum Analysis, RamanErb-b2 Receptor Tyrosine KinasesCell Line, TumorReceptors, ProgesteroneFemaleReceptors, EstrogenBiomarkers, Tumor

Author keywords

Raman spectroscopySERS nanoparticlesbreast cancer cell imagingcell permeabilizationmultiplexed imaging

Substances

Erb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneReceptors, EstrogenBiomarkers, TumorERBB2 protein, human

Authors and institutions

  • Alfred E. Mann Department of Biomedical Engineering, University of Southern California, 36- McClintock Ave, Los Angeles, California 90089, United States.
  • USC Michelson Center for Convergent Bioscience, University of Southern California, 1002 Childs Way, Los Angeles, California 90089, United States.
  • Keck School of Medicine of USC, Department of Population and Public Health Sciences, 1845 N Soto St, Los Angeles, California 90032, United States.

ORCID profiles: Pegah Bagheri, Olga E Eremina

Funding

  • NCI NIH HHS
  • NIBIB NIH HHS
  • U.S. Department of Health and Human Services

Cite

APA

Bagheri, P., Eremina, O. E., Dorgan, N., Millstein, J., & Zavaleta, C. (2025). A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c08079

Vancouver

Bagheri P, Eremina OE, Dorgan N, Millstein J, Zavaleta C. A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c08079

BibTeX
@article{Bagheri2025,
  author = {Bagheri, Pegah and Eremina, Olga E and Dorgan, Nicholas and Millstein, Joshua and Zavaleta, Cristina},
  title = {A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c08079}
}
Start for free →